A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants

Conditions: Migraine Interventions: Combination Product: Zavegepant 10 mg; Combination Product: Placebo - Control 1; Combination Product: Placebo - Control 2 Sponsors: Pfizer Not yet recruiting

https://clinicaltrials.gov/study/NCT06103734

Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials